Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

GS Malhi, D Bassett, P Boyce… - Australian & New …, 2015 - journals.sagepub.com
Objectives: To provide guidance for the management of mood disorders, based on scientific
evidence supplemented by expert clinical consensus and formulate recommendations to …

Treatment-resistant depression: therapeutic trends, challenges, and future directions

KS Al-Harbi - Patient preference and adherence, 2012 - Taylor & Francis
Background Patients with major depression respond to antidepressant treatment, but 10%–
30% of them do not improve or show a partial response coupled with functional impairment …

Genetic and clinical characteristics of treatment-resistant depression using primary care records in two UK cohorts

C Fabbri, SP Hagenaars, C John, AT Williams… - Molecular …, 2021 - nature.com
Abstract Treatment-resistant depression (TRD) is a major contributor to the disability caused
by major depressive disorder (MDD). Primary care electronic health records provide an …

Results of the European Group for the Study of Resistant Depression (GSRD)—basis for further research and clinical practice

L Bartova, M Dold, A Kautzky, C Fabbri… - The World Journal of …, 2019 - Taylor & Francis
Objectives: The overview outlines two decades of research from the European Group for the
Study of Resistant Depression (GSRD) that fundamentally impacted evidence-based …

Clinical guidelines for the management of treatment-resistant depression: French recommendations from experts, the French Association for Biological Psychiatry and …

D Bennabi, T Charpeaud, A Yrondi, JB Genty… - BMC psychiatry, 2019 - Springer
Background Clear guidance for successive antidepressant pharmacological treatments for
non-responders in major depression is not well established. Method Based on the …

[HTML][HTML] Identifying the common genetic basis of antidepressant response

O Pain, K Hodgson, V Trubetskoy, S Ripke… - … psychiatry global open …, 2022 - Elsevier
Background Antidepressants are a first-line treatment for depression. However, only a third
of individuals experience remission after the first treatment. Common genetic variation, in …

Personalized treatment approaches.

ZD Cohen, J Delgadillo, RJ DeRubeis - 2021 - psycnet.apa.org
In the modern history of psychotherapy, understanding the individual patient and how to
optimize treatment for each individual has been an important challenge. For the therapist …

Evidence-based pharmacotherapy of treatment-resistant unipolar depression

M Dold, S Kasper - International journal of psychiatry in clinical …, 2017 - Taylor & Francis
Abstract Treatment resistance to the antidepressive pharmacotherapy represents one of the
most important clinical challenges in the pharmacological management of unipolar …

[HTML][HTML] Switching and stopping antidepressants

N Keks, J Hope, S Keogh - Australian Prescriber, 2016 - ncbi.nlm.nih.gov
Switching and stopping antidepressants - PMC Back to Top Skip to main content NIH NLM Logo
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Preview …

Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment‐resistant depression

SJ Thomas, M Shin, MG McInnis… - … : The Journal of Human …, 2015 - Wiley Online Library
Treatment‐resistant depression (TRD) is a major health concern. More than 40% of patients
treated for major depressive disorder with an appropriate antidepressant dose for an …